Prognostic differences between routine invasive and conservative strategies for the management of high-risk, non-ST segment acute coronary syndromes: Experience from two consecutive periods in a single center

European Journal of Internal Medicine

Volumn 18, Issue 5, 2007, Pages 409-416

  Núñez, Julio ^a   Sanchis, Juan ^a   Núñez, Eduardo ^a   Bodi, Vicent ^a   Bertomeu González, Vicente ^a   Bosch, Maria J ^a   Santas, Enrique ^a   Fácila, Lorenzo ^a   Chorro, Francisco J ^a   Gómez, Cristina ^a   Consuegra, Luciano ^a   Llàcer, Angel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Conservative strategy; Invasive strategy; Non ST elevation acute coronary syndromes; Prognosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; NITRATE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; FEMALE; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK REDUCTION; ST SEGMENT;

EID: 34547697295     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2006.12.011     Document Type: Article

References (34)

1. Bertrand M.E., Simoons M.L., Fox K.A., et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 23 (2002) 1809-1840
2. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
3. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344 (2001) 1879-1887
4. Fox K.A., Poole-Wilson P., Clayton T.C., et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 366 (2005) 914-920
5. Wallentin L., Lagerqvist B., Husted S., Kontny F., Stahle E., and Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 356 (2000) 9-16
6. Mehta S.R., Cannon C.P., Fox K.A., et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. Jama 293 (2005) 2908-2917
7. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 89 (1994) 1545-1556
8. Boden W.E., O'Rourke R.A., Crawford M.H., et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med 338 (1998) 1785-1792
9. de Winter R.J., Windhausen F., Cornel J.H., et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 353 (2005) 1095-1104
10. Ottervanger J.P., Armstrong P., Barnathan E.S., et al. Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS. Eur Heart J 25 (2004) 1494-1501
11. Stenestrand U., and Wallentin L. Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study. Lancet 359 (2002) 1805-1811
12. Bhatt D.L., Roe M.T., Peterson E.D., et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Jama 292 (2004) 2096-2104
13. Tunis S.R., Stryer D.B., and Clancy C.M. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. Jama 290 (2003) 1624-1632
14. Steg P.G., Goldberg R.J., Gore J.M., et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 90 (2002) 358-363
15. Sanchis J., Bodi V., Llacer A., et al. Risk stratification of patients with acute chest pain and normal troponin concentrations. Heart 91 (2005) 1013-1018
16. Sanchis J., Bodi V., Nunez J., et al. New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score. J Am Coll Cardiol 46 (2005) 443-449
17. Rosenbaum P.R., and Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-50
18. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
19. Klungel O.H., Martens E.P., Psaty B.M., et al. Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol 57 (2004) 1223-1231
20. Rubin D.B., and Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics 52 (1996) 249-264
21. Fox K.A., Poole-Wilson P.A., Henderson R.A., et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 360 (2002) 743-751
22. Bodi V., Sanchis J., Llacer A., et al. An invasive strategy in non-ST-segment elevation acute coronary syndromes. From large trials to the real world. Rev Esp Cardiol 57 (2004) 1143-1150
23. Bach R.G., Cannon C.P., Weintraub W.S., et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 141 (2004) 186-195
24. Januzzi J.L., Cannon C.P., DiBattiste P.M., Murphy S., Weintraub W., and Braunwald E. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). Am J Cardiol 90 (2002) 1246-1249
25. Januzzi Jr. J.L., Buros J., and Cannon C.P. Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trial. Clin Cardiol 28 (2005) 238-242
26. Keeley E.C., Kadakia R., Soman S., Borzak S., and McCullough P.A. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 92 (2003) 509-514
27. Steg P.G., Dabbous O.H., Feldman L.J., et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 109 (2004) 494-499
28. Liistro F., Angioli P., Falsini G., et al. Early invasive strategy in elderly patients with non-ST elevation acute coronary syndrome: comparison with younger patients regarding 30 day and long term outcome. Heart 91 (2005) 1284-1288
29. Botkin N.F., Spencer F.A., Goldberg R.J., Lessard D., Yarzebski J., and Gore J.M. Changing trends in the long-term prognosis of patients with acute myocardial infarction: a population-based perspective. Am Heart J 151 (2006) 199-205
30. Goldberg R.J., Currie K., White K., et al. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 93 (2004) 288-293
31. Ioannidis J.P., Karvouni E., and Katritsis D.G. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol 42 (2003) 1406-1411
32. Jeremias A., Baim D.S., Ho K.K., et al. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol 44 (2004) 1210-1214
33. Stone G.W., Mehran R., Dangas G., Lansky A.J., Kornowski R., and Leon M.B. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation 104 (2001) 642-647
34. Fox K.A., Goodman S.G., Klein W., et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 23 (2002) 1177-1189